| 000 | 01577 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514181708.0 | ||
| 264 | 0 | _c20040408 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/382033 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDykes, Carrie | |
| 245 | 0 | 0 |
_aDetection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudine. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cMar 2004 |
||
| 300 |
_a1091-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 |
_aHIV Protease _xgenetics |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndinavir _xtherapeutic use |
| 650 | 0 | 4 |
_aLamivudine _xtherapeutic use |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 |
_aZidovudine _xtherapeutic use |
| 700 | 1 | _aNajjar, Joe | |
| 700 | 1 | _aBosch, Ronald J | |
| 700 | 1 | _aWantman, Michael | |
| 700 | 1 | _aFurtado, Manohar | |
| 700 | 1 | _aHart, Stephen | |
| 700 | 1 | _aHammer, Scott M | |
| 700 | 1 | _aDemeter, Lisa M | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 189 _gno. 6 _gp. 1091-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/382033 _zAvailable from publisher's website |
| 999 |
_c14719902 _d14719902 |
||